Eli Lilly to buy Merida Biosciences in $2.88 billion deal

LLY•2026-08-31

Eli Lilly to acquire Merida Biosciences

Eli Lilly said on Monday it would acquire privately held Merida Biosciences for up to $2.88 billion in cash, expanding its efforts to develop treatments for immunity-related and allergic diseases.

Eli Lilly to buy Merida Biosciences in $2.88 billion deal

Eli Lilly to acquire Merida Biosciences

Related News

Ascendis enters global settlement, license deal with BioMarin for YUVIWEL royalties

Redhill Divests Talicia To Apotex For $18 Million Cash Upfront Plus Milestones

AirJoule Technologies Corporation <AIRJ.O>: Needham initiates coverage with hold rating

Intel gains; report says SK Hynix considering it for chip production

A-6684 reports purchase of 5,000 Tofutti Brands common shares worth $2,250